Prudential Financial Inc. lowered its position in shares of Heska Corporation (NASDAQ:HSKA) by 62.3% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 43,179 shares of the medical research company’s stock after selling 71,400 shares during the period. Prudential Financial Inc. owned approximately 0.61% of Heska Corporation worth $4,407,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Victory Capital Management Inc. purchased a new stake in shares of Heska Corporation during the first quarter valued at approximately $101,000. BNP Paribas Arbitrage SA raised its stake in shares of Heska Corporation by 1,306.0% during the first quarter. BNP Paribas Arbitrage SA now owns 1,167 shares of the medical research company’s stock valued at $123,000 after purchasing an additional 1,084 shares during the period. State of Alaska Department of Revenue purchased a new stake in shares of Heska Corporation during the second quarter valued at approximately $127,000. LS Investment Advisors LLC raised its stake in shares of Heska Corporation by 411.2% during the second quarter. LS Investment Advisors LLC now owns 1,278 shares of the medical research company’s stock valued at $130,000 after purchasing an additional 1,028 shares during the period. Finally, Mason Street Advisors LLC purchased a new stake in shares of Heska Corporation during the first quarter valued at approximately $144,000. Institutional investors own 81.36% of the company’s stock.

A number of research firms have recently issued reports on HSKA. BidaskClub lowered shares of Heska Corporation from a “buy” rating to a “hold” rating in a research note on Monday, August 14th. Benchmark Co. reiterated a “buy” rating and set a $120.00 price objective (up previously from $106.00) on shares of Heska Corporation in a research note on Wednesday, August 9th. Zacks Investment Research upgraded shares of Heska Corporation from a “hold” rating to a “buy” rating and set a $109.00 price objective on the stock in a research note on Friday, August 4th. B. Riley reiterated a “neutral” rating and set a $96.50 price objective on shares of Heska Corporation in a research note on Thursday, August 3rd. Finally, Aegis lifted their price objective on shares of Heska Corporation from $114.50 to $129.50 and gave the company a “buy” rating in a research note on Tuesday, August 1st. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $105.20.

ILLEGAL ACTIVITY WARNING: “Prudential Financial Inc. Has $4.41 Million Stake in Heska Corporation (HSKA)” was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The original version of this piece of content can be read at https://www.watchlistnews.com/prudential-financial-inc-has-4-41-million-stake-in-heska-corporation-hska/1577173.html.

Shares of Heska Corporation (NASDAQ:HSKA) opened at 88.87 on Thursday. The company has a market cap of $642.17 million, a price-to-earnings ratio of 45.30 and a beta of 0.91. Heska Corporation has a 52 week low of $46.51 and a 52 week high of $115.00. The company has a 50 day moving average of $98.08 and a 200-day moving average of $98.84.

Heska Corporation (NASDAQ:HSKA) last announced its earnings results on Thursday, August 3rd. The medical research company reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.07. The firm had revenue of $34.30 million during the quarter, compared to analysts’ expectations of $33.35 million. Heska Corporation had a return on equity of 15.87% and a net margin of 10.70%. The company’s revenue was up 14.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.35 earnings per share. On average, equities research analysts expect that Heska Corporation will post $2.04 earnings per share for the current fiscal year.

In other news, CFO John Mcmahon sold 2,608 shares of the company’s stock in a transaction that occurred on Wednesday, August 30th. The stock was sold at an average price of $101.17, for a total transaction of $263,851.36. Following the completion of the transaction, the chief financial officer now directly owns 193 shares in the company, valued at $19,525.81. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Nancy Wisnewski sold 825 shares of the company’s stock in a transaction that occurred on Thursday, August 31st. The stock was sold at an average price of $102.21, for a total value of $84,323.25. Following the transaction, the executive vice president now owns 38,114 shares of the company’s stock, valued at $3,895,631.94. The disclosure for this sale can be found here. 14.70% of the stock is owned by insiders.

About Heska Corporation

Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.

Institutional Ownership by Quarter for Heska Corporation (NASDAQ:HSKA)

Receive News & Ratings for Heska Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.